about
Reporting bias in medical research - a narrative reviewBenzodiazepines for generalised anxiety disorder (GAD)Hydroxyzine for generalised anxiety disorderHydroxyzine for generalised anxiety disorderMedia-delivered cognitive behavioural therapy and behavioural therapy (self-help) for anxiety disorders in adultsPsychological therapies for generalised anxiety disorderPsychological therapies for generalised anxiety disorderA taxpayer-funded clinical trials registry and results databaseCanadian clinical practice guidelines for the management of anxiety, posttraumatic stress and obsessive-compulsive disordersExercise as Treatment for Anxiety: Systematic Review and Analysis.Quetiapine monotherapy in acute treatment of generalized anxiety disorder: a systematic review and meta-analysis of randomized controlled trialsEmerging drugs for the treatment of anxietyAre child and adolescent responses to placebo higher in major depression than in anxiety disorders? A systematic review of placebo-controlled trials.Stepped care for depression and anxiety: from primary care to specialized mental health care: a randomised controlled trial testing the effectiveness of a stepped care program among primary care patients with mood or anxiety disorders.Management of generalized anxiety disorder in primary care: identifying the challenges and unmet needs.An electronic health record driven algorithm to identify incident antidepressant medication users.Evidence-based guidelines for the pharmacological treatment of anxiety disorders: recommendations from the British Association for Psychopharmacology.Pharmacotherapy of anxiety disorders: a critical reviewCriminal justice and alcohol treatment: results from a national sample.Clinical efficacy and safety of fluoxetine in generalized anxiety disorder in Chinese patients.Spectrum of anxiety disorders: diagnosis and pharmacologic treatment.Anxiety: an evolutionary approach.Evidence-based review of clinical outcomes of guideline-recommended pharmacotherapies for generalized anxiety disorder.The impact of medication on health-related quality of life in patients with generalized anxiety disorder.Genome-wide association study of generalized anxiety symptoms in the Hispanic Community Health Study/Study of Latinos.Efficacy of Silexan in subthreshold anxiety: meta-analysis of randomised, placebo-controlled trials.Psychological morbidity among young adults attending primary care: a retrospective study.Pharmacological treatment of anxiety disorders in children and adolescents: a review for practitioners.Inhibition of the G9a/GLP histone methyltransferase complex modulates anxiety-related behavior in mice.Reproductive steroid receptors and actions in the locus coeruleus of male macaques: Part of an aggression circuit?
P2860
Q21203744-6168AB86-7269-4E5A-AC55-5EBD076BFC30Q24197945-ACC744C0-410F-4BDC-8C02-650B884AB156Q24235649-B17E2829-80E3-40DE-A417-9AC0AF72F7E2Q24243207-F4266431-51DB-4BD7-BCE9-7ECA6059CD8FQ24243715-6A09097D-BDAE-4D73-92B9-D70AE09C17F6Q24244659-6F48ADA4-1DA2-422E-9AB1-2AED3D6FCE02Q24246330-3AAC98B2-ECA3-49CD-9A0F-747B6BF5C781Q24798073-BA1DB3B8-892F-4882-9CD1-EDF648D56A80Q27009995-E4332E67-02B1-4822-80FD-DD2D56F7A7D5Q27693304-A9B86D91-DC56-4050-96B8-16252D11DE29Q28069524-9FD90696-16B7-4A76-8A7C-30F32E3A9396Q28083141-F5F8A48B-9FAF-49DA-BF7C-27333D144C88Q33350235-0D00BB1C-B038-48CA-8153-21888B88D8B6Q33461809-C02B6450-15B3-4196-91C2-2A5EA21FD962Q34024109-585C155A-FA39-417B-9C9B-B7014C08848BQ34100018-B0999869-A94C-41C3-BC68-B14120392BC6Q34465555-4D47C6BD-BC06-4CFD-ABE2-2A514B853F29Q35686859-17B757A1-94CB-4139-A0CE-4DEA99390AA4Q36457210-0697DC15-B7D7-48F9-8AD4-2BC8F1FE8C6DQ37281390-0D7B805B-EE93-4681-906E-9FBDCCB51620Q37871044-C4E67D32-5011-4153-A7C1-05161A7339BBQ37966145-78F9EC5B-E015-4CC6-A9C9-559C394A93B4Q38031324-DF73A450-DCDC-4074-8856-7F632FD2FD75Q38291371-3FF07258-EBD4-4DCC-B35B-FF7428E36333Q39783086-2C18D238-A4B9-4191-8D85-A93907A41EA2Q47576191-BE986049-85CD-4DA5-B265-A0CF272367F0Q48072475-4BF1AA72-493E-4BFF-8B41-D613D57C1A78Q49277998-F8E0A867-1CF1-46F3-B9FC-E385993FF106Q50123806-D0E91554-C843-4B66-8E12-BB6E5DF94343Q50908300-A0EE7E3C-CBE0-470E-B32D-FCD1AA540333
P2860
description
2003 nî lūn-bûn
@nan
2003 թուականի Ապրիլին հրատարակուած գիտական յօդուած
@hyw
2003 թվականի ապրիլին հրատարակված գիտական հոդված
@hy
2003年の論文
@ja
2003年論文
@yue
2003年論文
@zh-hant
2003年論文
@zh-hk
2003年論文
@zh-mo
2003年論文
@zh-tw
2003年论文
@wuu
name
Antidepressants for generalised anxiety disorder (GAD)
@ast
Antidepressants for generalised anxiety disorder (GAD)
@en
Antidepressants for generalised anxiety disorder (GAD)
@en-gb
Antidepressants for generalised anxiety disorder (GAD)
@nl
type
label
Antidepressants for generalised anxiety disorder (GAD)
@ast
Antidepressants for generalised anxiety disorder (GAD)
@en
Antidepressants for generalised anxiety disorder (GAD)
@en-gb
Antidepressants for generalised anxiety disorder (GAD)
@nl
prefLabel
Antidepressants for generalised anxiety disorder (GAD)
@ast
Antidepressants for generalised anxiety disorder (GAD)
@en
Antidepressants for generalised anxiety disorder (GAD)
@en-gb
Antidepressants for generalised anxiety disorder (GAD)
@nl
P2093
P2860
P1476
Antidepressants for generalised anxiety disorder (GAD)
@en
P2093
Angelo ABC Batista Miralha da Cunha
Juliano JSS dos Santos Souza
Ricardo RS Schmitt
P2860
P356
10.1002/14651858.CD003592
P577
2003-04-22T00:00:00Z